NASDAQ: ZY - Zymergen Inc.

Yield per half year: 0%
Sector: Healthcare

Share chart Zymergen Inc.


About

Zymergen Inc. разрабатывает, проектирует и оптимизирует микробы для промышленного применения в США, Азии и Европе. У компании есть платформа, которая рассматривает геном как пространство поиска для выявления генетических изменений, которые улучшают экономику био-продуктов ее клиентов для ряда отраслей, включая химическую промышленность и материалы, сельское хозяйство и фармацевтику. Платформа Zymergen используется для открытия новых молекул, обеспечивающих уникальные свойства материалов. Компания была зарегистрирована в 2013 году и базируется в Эмеривилле, Калифорния.


Main settings

P/S 31.51
EV/EBITDA 0.2986
EBITDA -0.2187
Цена ао 2.43
Сайт http://www.zymergen.com
Число акций ао 97 млн
P/BV 1.2915
Выручка 0.0154
Див.доход ао 0
Change price per day: 0% (2.43)
Change price per week: 0% (2.43)
Change price per month: 0% (2.43)
Change price per 3 month: 0% (2.43)
Change price per half year: 0% (2.43)
Change price per year: 0% (2.43)
Change price per 3 year: -93.16% (35.53)
Change price per year to date: 0% (2.43)


All parameters ⇨

Grade

Underestimation

Title Value Grade
P/S 31.51 1
P/BV 1.2915 9
P/E 0 0
EV/EBITDA 0.2986 10
Total:

Efficiency

Title Value Grade
ROA, % -73.48 0
ROE, % -113.14 0
Total:

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total:

Debt

Title Value Grade
Debt/EBITDA -0.5876 10
Total:

Growth impulse

Title Value Grade
Profit growth, % 0 0
Share price growth, % 0 0
Dividend growth, % 0 0
Total:

Insider trading

Transaction date Date of disclosure Insider Type Price Volume Quantity Share before, % Share after, % Document
02.09.2022 07.09.2022 Serber Zachariah
Chief Science Officer
Sale 2.21 7 222 3268 0 0 link
02.09.2022 07.09.2022 Kim Mina
Chief Legal Officer
Sale 2.21 7 536 3410 0 0 link
02.09.2022 07.09.2022 Singh Enakshi
Chief Financial Officer
Sale 2.21 8 681 3928 0 0 link
11.08.2022 15.08.2022 Serber Zachariah
Chief Science Officer
Sale 3.91 21 251 5435 0 -0.01 link
02.06.2022 06.06.2022 Serber Zachariah
Chief Science Officer
Sale 1.68 4 724 2812 0 0 link
02.06.2022 06.06.2022 Kim Mina
Chief Legal Officer
Sale 1.68 4 938 2939 0 0 link
01.02.2022 03.02.2022 Kimball Aaron
Chief Technology Officer
Sale 5.06 126 500 25000 0 -0.02 link
31.01.2022 02.02.2022 Serber Zachariah
Chief Science Officer
Sale 5.03 27 338 5435 0 -0.01 link

Main owners

Institutions Volume Share, %
SB INVESTMENT ADVISERS (UK) LTD 26614219 25.99
ARK Investment Management LLC 5004359 4.89
Perceptive Advisors LLC 3266664 3.19
BAMCO Inc 2666218 2.6
Baron Capital Management Inc 1994904 1.95
Redmile Group, LLC 1522900 1.49
J.P. Morgan Investment Management, Inc. 1295413 1.27
JPMorgan Asset Management (Europe) S.à r.l. 1203876 1.18
ICONIQ Capital, LLC 990765 0.97
Cota Capital Management, LLC 989388 0.97
Janus Henderson Investors 874696 0.85
Comprehensive Financial Management LLC 769321 0.75
Morgan Stanley Investment Management, Inc. 601110 0.59
Tao Capital Management LP 247690 0.24
PURA VIDA INVESTMENTS, LLC 214577 0.21
Lincoln Investment Advisors Corporation 195825 0.19
Goldman Sachs Asset Management, L.P. 176640 0.17
Equitable 142597 0.14
Voya Investments, LLC 134436 0.13
The Variable Annuity Life Insurance Company 113501 0.11
JP Morgan Asset Management (UK) Ltd 94498 0.09
Putnam Investment Management, LLC 83576 0.08
JPMorgan Chase Bank 67724 0.07
Bill & Melinda Gates Foundation 59970 0.06
OFI LUX 20269 0.02
Emerge Canada Inc. 16080 0.02
Putnam 5849 0.01
Envestnet Asset Management Inc 227 0
Baillie Gifford Overseas Limited 0 0

Similar companies



Company management

Head Job title Payment Year of birth
Mr. Zachariah Serber Ph.D. Co-Founder & Director 353.49k 1975 (49 years)
Ms. Enakshi Singh Chief Financial Officer 390.3k 1978 (46 years)
Ms. Mina Kim Corp. Sec. N/A 1974 (50 years)
Mike Dulin Director of Communications N/A
Mr. Jay T. Flatley Chairman & Acting CEO 1.03M 1953 (71 year)
Mr. Lincoln Germain Chief Commercial Officer N/A
Mr. Subodh S. Deshmukh Chief Devel. Officer N/A
Mr. Dmitriy Ryaboy Chief Technology Officer N/A
Mr. Devin Scannell Sr. VP of Drug Discovery N/A
Mr. Duane Valz J.D. Sec. N/A

About company

Address: United States, EmeryVille, CA , 5980 Horton Street - open in Google maps, open in Yandex maps
Website: http://www.zymergen.com
Phone: +415 801 8073